Richard S Greenberg Insider Trading $NTVA NEXIEN BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard S Greenberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard S Greenberg. Richard S Greenberg is Chief Executive Officer in NEXIEN BIOPHARMA, INC. ($NTVA) and EVP in NEXIEN BIOPHARMA, INC. ($NTVA) and EVP and Chairman in Kinder Holding Corp. ($KDRH).
Richard S Greenberg in NEXIEN BIOPHARMA, INC.
Trading Symbol: NTVAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard S Greenberg: Chief Executive Officer, EVP and Chairman
Holdings: 3,685,192 shares
Current Value: $36,852
Latest Transaction: Apr 05 2021
$NTVA Market Capitalization: $240726.00
$NTVA Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard S Greenberg in NEXIEN BIOPHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 3,685,192 | 2.7 M to 3.7 M (+37.24 %) |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.05 | 1,062,953 | 48,045 | 1,062,953 | |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 46,026 | 1,062,953 | |
Nov 30 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.04 | 1,062,953 | 42,837 | 1,062,953 | |
Aug 21 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Option Exercise | A | 0.08 | 2,500,000 | 200,000 | 2,500,000 | |
Aug 14 2020 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | Chief Executive Off ... | Buy | C | 0.01 | 1,800,880 | 25,212 | 2,688,880 | 888 K to 2.7 M (+202.80 %) |
Oct 29 2018 | NTVA | NEXIEN BIOPHARMA, ... | Greenberg Richard S | EVP | Option Exercise | A | 0.66 | 100,000 | 65,500 | 100,000 | |
Jul 26 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | A | 0.54 | 150,000 | 81,000 | 150,000 | |
Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | X | 0.38 | 88,000 | 33,440 | 0 | |
Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Option Exercise | J | 0.38 | 88,000 | 33,440 | 88,000 | |
Jun 29 2018 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | X | 0.38 | 88,000 | 33,440 | 888,000 | 800 K to 888 K (+11.00 %) |
Nov 30 2017 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 503,303 | 0 | 800,000 | 296.7 K to 800 K (+169.64 %) |
Nov 30 2017 | KDRH | Intiva BioPharma I ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 15,099,083 | 0 | 24,000,000 | 8.9 M to 24 M (+169.64 %) |
Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 1,780,183 | 0 | 1,780,183 | 0 to 1.8 M |
Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Buy | J | 0.00 | 53,405,501 | 0 | 53,405,501 | 0 to 53.4 M |
Oct 18 2017 | KDRH | Kinder Holding Cor ... | Greenberg Richard S | EVP and Chairman | Sell | J | 0.00 | 20,000,000 | 0 | 0 | 20 M to 0 (-100.00 %) |
Page: 1